Medtecs International Corporation Limited reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was USD 52.63 million compared to USD 56.24 million a year ago. Net loss was USD 21.01 million compared to USD 28.6 million a year ago.

Basic loss per share from continuing operations was USD 0.03856 compared to USD 0.05244 a year ago. Diluted loss per share from continuing operations was USD 0.03856 compared to USD 0.05244 a year ago.